This grant funds high-impact ovarian cancer research with strong preliminary data, supporting projects from basic to translational stages (excluding clinical trials), with an option for collaborative investigator teams.
Funder: Dept. of the Army -- USAMRAA
Due Dates: July 13, 2026: Pre-Application (Preproposal) | October 1, 2026: Full Application | October 6, 2026: End of Application Verification
Funding Amounts: Up to $1.05M total (single PI) or $1.40M total (Partnering PI option) over 4 years; approx. 14 awards, $16.45M total program funding.
Summary: Supports high-impact, non-clinical trial research to address critical needs in ovarian cancer or patient/survivor care, with required preliminary data.
This opportunity supports investigator-initiated research projects that address critical needs in ovarian cancer research or patient/survivor care. Research may span basic to translational phases but must exclude clinical trials. Projects should demonstrate a strong scientific rationale, include relevant preliminary data, and be designed to make a significant contribution to the field. The Partnering Principal Investigator (PI) Option allows two investigators to collaborate synergistically on a single project, with each PI receiving a separate award.